MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today reported financial results for the third quarter ended September 30, 2026, and provided a corporate update. Third Quarter 2026 Financial Highlights Total revenue of $23.1 million in the third quarter of 2026 RNS System revenue of $22.9 million in the quarter, representing 1.4% growth compared to the third quarter of 2025 Net los

Subscribe to Our Newsletter

We keep your data private and share your data only with third parties that make this service possible. See our Privacy Policy for more information.